| Revenue growth | FY26: -8% YoY; Q4 FY26: -31% YoY. |
|---|---|
| Margins | FY26 EBITDA margin 31% vs 37% YoY. |
| Order book | Received trial orders in Advanced Contrast Media from Japan. |
| Demand visibility | PI segment de-stocking complete; robust orders expected. |
| Management confidence | Strong visibility on underlying demand; expecting normalization. |
Growth
FY26 revenue fell 8% YoY; PAT dropped 19% to ₹2,478 mn. Q4 FY26 showed QoQ recovery with revenue up 22%.
Outlook
Ground-breaking for Vizag project; R&D center completion by Sept 2026. Expect normalization and robust PI segment orders.
Risks
Declining revenues in PI & API segment (-35.6% YoY) and increased operating costs impacting EBITDA margins.
Earnings Call filed with BSE, NSE: BLUEJET. Summary written with AI assistance from the document.
Blue Jet Healthcare Ltd: key numbers
- Share price
- ₹570.65
- Market cap
- ₹9,899 Cr
- Revenue (annual)
- ₹947.3 Cr
- Net profit (annual)
- ₹247.8 Cr
- P/E (TTM)
- 42.1×Sector 50.4×
- Promoter holding
- 73.15%-6.66% QoQ
- FII holding
- 0.63%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Blue Jet Healthcare Ltd
All →Blue Jet Healthcare Annual General Meeting
Blue Jet Healthcare held its 58th AGM, approving audited financials, a Re 1.20 dividend, and director re-appointments. No material amendments were noted.
Blue Jet Healthcare Investor Presentation: Key Takeaways
Blue Jet Healthcare reported Q1 FY27 revenue of INR 293 crores (+25% QoQ) and EBITDA of INR 98 crores. Management highlighted a shift toward higher-value PI and API verticals alongside significant upcoming capex.
Blue Jet Healthcare Earnings Call Transcript: Key Takeaways
Blue Jet Healthcare reported Q1 FY27 revenue of ₹2,931mn, up 25% QoQ but down 17% YoY. Management is focusing on capacity expansion and forward integration into advanced contrast media intermediates.
Blue Jet Healthcare Investor Presentation: Key Takeaways
Blue Jet Healthcare reported Q1 FY27 Revenue of ₹2,931mn, up 25% QoQ but down 17.4% YoY. Strategy focuses on expanding R&D and CDMO adjacencies.
Blue Jet Healthcare Q1 FY27 Results: Net Profit ₹78.3 Cr, Down 14.1% YoY
Blue Jet Healthcare Ltd reported revenue from operations of ₹293.1 Cr (-17.4% YoY) and net profit of ₹78.3 Cr (-14.1% YoY) for Q1 FY27.
- Key figure
- Net profit ₹78.3 Cr · -14.1% YoY
Blue Jet Healthcare Earnings Call: Key Takeaways
Blue Jet Healthcare reported FY26 revenue of ₹947cr (-8% YoY) and PAT margin of 26%. Management highlights transition from investment to commercialization phase via significant Vizag greenfield expansion.